MedPath

The effect of clopidogrel in prevention of access graft thrombosis in upper extremity.

Phase 2
Conditions
Chronic Renal Failure -Hemodialysis.
Chronic Renal Failure -Dialysis
Registration Number
IRCT2013012412256N1
Lead Sponsor
Kermanshah Univesity of Medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Inclusion criterion: patients with end-stage renal failure who need to vascular access graft placement in upper extremity for hemodialysis.
Exclusion criteria: pationts with advanced malignancies and hyper coagolation states; pationts with a history of venous access thrombosis; thrombocytopenia (<100000/ml); thrombpcytosis (>450000/ml); erythrocytosis (hematocrite>55%); patients who receiving warfarin, aspirin or other salicylates, dipyridamole,sulfinpyrazone and ticlopidine or other conditions that anti platelet drugs are contraindicated.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Thrombosis. Timepoint: Monthly for 6months. Method of measurement: Dupler Sonography and clinical examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath